UI Healthcare LogoInternal Medicine Home Pagespacer imageEducation InformationPatient Care InformationResearch Informationspacer imageDivisions of the DepartmentFaculty
Diversity and Culture ConferencesNews and EventsGiving Opportunitiesspacer imageServicesIntranet (login required)Useful LinksContact Usspacer imageThe University of Iowa

 

UI Healthcare Navigation Bar UI Healthcare Home Page About Us Appointments Contact UI Healthcare Staff Departments Health Topics Search

Department of Internal Medicine

Hematology, Oncology and Blood & 
Marrow Transplantation Faculty


Brian K. Link, M.D.

  Additional Publications

  1. Byrd, J.C., Shinn, C.A., Pearson, M.D., Flinn, I.W., Link, B.K., Wang, H., Weiner, G., Grover, M.R.: Hu IDI0 induces apototosis in vitro in human chronic lymphocytic leukemia cells (CLL) independent of compliant mediated lysis but requires Fcj receptor ligation. Blood (in press 2001).
  2. Davis, T., Grillo-Lopez, A., White, C., McLaughlin, P., Czuczman, M., Link, B., Maloney, D., Weaver, R., Rosenberg, J., and Levy, R. Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin's Lymphoma: Safety and Efficacy of Retreatment. J Clin Oncol. 18:3135-3143, 2000.
  3. Warren, T.W., Shannon, M., Link, B.K., A phase I Study of CPG 7909 in Patients with Previously Treated Non Hodgkin's Lymphoma. Clinical Lymphoma (In Press, 2001).
  4. Vose, J.M., Link, B.K., Grossbard, M., Fisher, R.I., Czuczman, M., Gilman, P., Lowe, A.M,.: Phase II Pilot Study of the Safety and Efficacy of Rituximab in combination with CHOP Chemotherapy in Patients with Previously Untreated Intermediate or High-Grade NHL. J Clin Oncol 2001 19: 389-397.
  5. Buban, G., Link, B.K., Doucette, W. Influences on Oncologists' Adoption of New Agents in Adjuvant Chemotherapy of Breast Cancer J. Clin Ocol. 2001 19: 954-959.
  6. Jahrsdörfer, B., Hartmann, G., Racila, E., Jackson, W., Mühlenhoff, L., Meinhardt, G., Endres, S., Link, B.K., Krieg, A.M., Weiner, G.J.: CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens. J. Leukocyte Biol . 2001.
  7. Treon, S., Agus, D.B., Link, B.K., Rodrigues, G., Molina, A., Lacy, M.Q., Fisher, D.C., Emmanouilides, C., Richards, A., Clark, B., Lucas, M.S., Schlossman, R., Anderson, K.C., and Byrd, J.C.: A Retrospective Study on the Activity of Rituximab in Patients with Waldenstrom's Macroglobulinemia. Journal of Immunotherapy, June 2001.
  8. Link, B.K., Budd, T.G., Scott, S., Dickman, E., Paul, D., Lawless, G., Lee, M., Fridman, M., Ford, J., and Carter, W.B. Delivering Adjuvant Chemotherapy to Women with Early-Stage Breast Cancer: Current Patterns of Care. In Press Cancer 2001.
  9. Sheri A. Kostelny, Brian K. Link, J. Yun Tso, Max Vasquez, Brett H. Jorgensen, Hong Wang, William C. Hall, and George J. Weiner. Humanization and Characterization of the Anti-HLA-DR Antibody 1D10 In Press Int J Can 2001.

Previous Page


UI Healthcare Home | About Us | Appointments | Contact UI Healthcare | Departments | Health Library | Search

Home | Education | Patient Care | Research
Divisions | Faculty | Conferences | News & Events | Giving Opportunities
Services | Intranet | Useful Links | Contact Us